FindTrial
Sign In

Evaluation of the efficacy of traditional Chinese medicine on severe/critical COVID-19 patients based on a retrospective cohort study

Evaluation of the efficacy of traditional Chinese medicine on severe/critical COVID-19 patients based on a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080354
Enrollment
Unknown
Registered
2024-01-26
Start date
2023-05-01
Completion date
Unknown
Last updated
2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Traditional Chinese Medicine Treatment Group:N/A
Treatment group without TCM:N/A

Sponsors

The First Affiliated Hospital to Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) The patient was diagnosed as severe/critical; (2) Aged >= 18 years old.

Exclusion criteria

Exclusion criteria: (1) Delirious, consciousness disorder, dementia, all kinds of mental patients; (2) Pregnant and lactating women; (3) Patients with active pulmonary tuberculosis;

Design outcomes

Primary

MeasureTime frame
Compound events rate;All-cause mortality;Single symptom disappearance rate;—

Secondary

MeasureTime frame
Hospital length of stay;Nucleic acid turning negative time;Mechanical ventilation time;Chest CT;White blood cell, Procalcitonin, C-reaction protein, et al.;Arterial blood gasblood gas measurement;—

Countries

China

Contacts

Public ContactLi Suyun

The First Affiliated Hospital to Henan University of Chinese Medicine

lisuyun2000@126.com+86 371 6624 8624

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026